CLS receives strong China patent for the TRANBERG® technology and the imILT® method
Clinical Laserthermia Systems (CLS) (publ), has now an approved patent in China covering the important parts of the technology in the TRANBERG®|Thermal Therapy System and for the unique content in the company’s imILT treatment for metastatic cancer. The patent is named ”Apparatus and methods for determining a property of a tissue”, with expiration year 2027. “CLS now has an excellent patent protection in China. We have further developed our European basic patent for immunological treatment, and thereby obtained an enhanced protection for both technology and method on the Chinese market”,